5 Best Low-Risk Dividend Stocks to Invest In

4. Johnson & Johnson (NYSE:JNJ)

Dividend Yield as of December 7: 2.57%
Beta Value: 0.57

One of the leading Big Pharma companies, Johnson & Johnson (NYSE:JNJ) was lauded by Morgan Stanley in December as the company plans to separate its Consumer Health segment into an independent company. The firm raised its price target on the stock to $178 with an Equal Weight rating on the shares.

Johnson & Johnson (NYSE:JNJ) currently pays a quarterly dividend of $1.13 per share and has a dividend yield of 2.57%, as of December 7. The company is one of the best dividend stocks on our list as it has raised its dividends for 60 years in a row.

As of the close of Q3 2022, 85 hedge funds in Insider Monkey’s database owned stakes in Johnson & Johnson (NYSE:JNJ), up from 83 in the previous quarter. The collective value of these stakes is over $5.4 billion. Among these hedge funds, Fisher Asset Management was the company’s leading stakeholder in Q3.

Here’s what Distillate Capital Partners LLC said about Johnson & Johnson (NYSE:JNJ) in its Q2 2022 investor letter:

“Johnson & Johnson was among the 2 largest trims at around 1% each. Each stock was up 1% in the quarter compared to the 16% price decline for the S&P 500 and the positions were reduced as the valuations became somewhat less appealing, though still attractive enough to warrant inclusion.”